SCHEMBL26790983

SCHEMBL26790983

CC[C@H]1CCN(C(=O)C2CC2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.45
POLB P06746 1/20 0.44
DPP8 Q6V1X1 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
HSD11B1 P28845 2/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 3/20 0.42
CHRNB2 P17787 4/20 0.42
CHRNA3 P32297 4/20 0.42
CHRNA4 P43681 4/20 0.42
CHRNB3 Q05901 3/20 0.42
CHRNA6 Q15825 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTT P42858 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.41
FASN P49327 2/20 0.41
TSHR P16473 1/20 0.41
CHRNB4 P30926 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17715716 0.91 HSD11B1 (0.56) HPGDHSD11B1ALDH1A1CHRNB2CHRNA3
SCHEMBL24671755 0.90 HTT (0.44) DPP8DPP7HSD11B1ALDH1A1SMN1; SMN2
SCHEMBL19176806 0.89 HPGD (0.52) HPGDPOLBHSD11B1PKMALDH1A1
SCHEMBL12509435 0.88 HPGD (0.54) HPGDPOLBHSD11B1PKMALDH1A1
SCHEMBL17816044 0.86 CHRNB2 (0.50) HPGDPOLBHSD11B1PKMCHRNB2
SCHEMBL25489003 0.85 HRH3 (0.54) DPP8DPP7HSD11B1ALDH1A1SMN1; SMN2
SCHEMBL20232739 0.84 HSD11B1 (0.47) HPGDHSD11B1ALDH1A1CHRNB2CHRNA3
SCHEMBL16015437 0.82 CHRNB2 (0.46) POLBDPP8DPP7ALDH1A1CHRNB2
SCHEMBL15515214 0.82 CHRNB2 (0.48) HPGDPOLBHSD11B1PKMALDH1A1
SCHEMBL15515212 0.82 CHRNB2 (0.48) HPGDPOLBHSD11B1PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220247-A1 LRRK2 INHIBITORS INTERLINE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed